MoneyWorks4Me

Dr.Reddy's Laboratories informs about disclosure

18 Jun 2022 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclsoure Requirements) Regulations, 2015, Dr.Reddy's Laboratories has informed that it attached the communication as sent to all the shareholders with respect to the deduction of tax at source on dividend pay-out.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..